Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Feb 15, 2024

SELL
$191.51 - $216.16 $2.12 Million - $2.39 Million
-11,078 Reduced 27.66%
28,977 $6.15 Million
Q2 2023

Feb 15, 2024

BUY
$187.64 - $206.25 $1.85 Million - $2.03 Million
9,864 Added 32.67%
40,055 $7.71 Million
Q2 2023

Jul 28, 2023

SELL
$187.64 - $206.25 $5.5 Million - $6.05 Million
-29,324 Reduced 42.38%
39,862 $7.67 Million
Q1 2023

Feb 14, 2024

BUY
$127.59 - $203.08 $2.74 Million - $4.37 Million
21,511 Added 44.94%
69,379 $14 Million
Q1 2023

May 04, 2023

BUY
$127.59 - $203.08 $5 Million - $7.96 Million
39,181 Added 130.58%
69,186 $14 Million
Q4 2022

Feb 14, 2024

BUY
$117.37 - $139.17 $2.2 Million - $2.61 Million
18,771 Added 64.51%
47,868 $6.15 Million
Q3 2022

Feb 15, 2024

BUY
$135.27 - $180.11 $4.08 Million - $5.44 Million
30,191 New
30,191 $4.13 Million
Q3 2022

Nov 08, 2022

BUY
$135.27 - $180.11 $154,884 - $206,225
1,145 Added 3.97%
30,005 $4.11 Million
Q2 2022

Feb 14, 2024

BUY
$108.81 - $179.33 $1.93 Million - $3.17 Million
17,693 Added 155.15%
29,097 $5.15 Million
Q2 2022

Jul 26, 2022

BUY
$108.81 - $179.33 $1.9 Million - $3.13 Million
17,456 Added 153.07%
28,860 $5.11 Million
Q1 2022

Feb 14, 2024

SELL
$119.61 - $157.85 $8,731 - $11,523
-73 Reduced 0.64%
11,404 $1.64 Million
Q1 2022

May 06, 2022

SELL
$119.61 - $157.85 $8,731 - $11,523
-73 Reduced 0.64%
11,404 $1.64 Million
Q4 2021

Feb 14, 2024

BUY
$142.57 - $190.86 $1.64 Million - $2.19 Million
11,477 New
11,477 $1.77 Million
Q4 2021

Feb 03, 2022

SELL
$142.57 - $190.86 $921,857 - $1.23 Million
-6,466 Reduced 36.04%
11,477 $1.77 Million
Q3 2021

Nov 10, 2021

BUY
$142.45 - $169.82 $3,276 - $3,905
23 Added 0.13%
17,943 $3.05 Million
Q2 2021

Aug 11, 2021

BUY
$135.08 - $161.1 $248,682 - $296,585
1,841 Added 11.45%
17,920 $2.83 Million
Q1 2021

Apr 26, 2021

SELL
$137.51 - $190.8 $643,959 - $893,516
-4,683 Reduced 22.56%
16,079 $2.23 Million
Q4 2020

Feb 10, 2021

BUY
$164.63 - $211.93 $3.42 Million - $4.4 Million
20,762 New
20,762 $3.64 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.